A Phase I/II Study of Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
Latest Information Update: 03 Sep 2024
At a glance
- Drugs Abemaciclib (Primary)
- Indications Kaposi's sarcoma
- Focus Adverse reactions; Therapeutic Use
- 28 Sep 2021 Planned initiation date (estimated date for recruitment of the first subject) changed to 4 Oct 2021.
- 25 Sep 2021 Planned initiation date (estimated date for recruitment of the first subject) changed from 30 Sep 2021 to 1 Oct 2021.
- 24 Sep 2021 Planned initiation date (estimated date for recruitment of the first subject) to 30 Sep 2021.